Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00042939
What this trial is testing

Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group 94
Very early researchActive Not RecruitingNCT01189643
What this trial is testing

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

Who this might be right for
SarcomaDesmoplastic Small Round Cell Tumor (DSRCT)
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)Ended earlyNCT00681876
What this trial is testing

Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hellenic Oncology Research Group 16
Testing effectiveness (Phase 2)Study completedNCT00193349
What this trial is testing

Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SCRI Development Innovations, LLC 60
Not applicableUnknownNCT01311050
What this trial is testing

A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
King Faisal Specialist Hospital & Research Center 46
Testing effectiveness (Phase 2)Study completedNCT00118235
What this trial is testing

Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Ended earlyNCT03251417
What this trial is testing

Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 11
Testing effectiveness (Phase 2)UnknownNCT06434090
What this trial is testing

Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 74
Testing effectiveness (Phase 2)UnknownNCT03641976
What this trial is testing

Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer

Who this might be right for
Unresectable Metastatic Right-sided Colon Cancer Starting First-line Combination ChemotherapyUnresectable Metastatic Right-sided Colon Cancer, Stage IV
Yonsei University 120
Early research (Phase 1)Study completedNCT02368860
What this trial is testing

OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
National Cancer Centre, Singapore 33
Large-scale testing (Phase 3)Study completedNCT00012389
What this trial is testing

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sanofi
Testing effectiveness (Phase 2)Study completedNCT06123468
What this trial is testing

Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma

Who this might be right for
Esophagogastric Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 58
Testing effectiveness (Phase 2)Study completedNCT00005076
What this trial is testing

Cetuximab and Irinotecan in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Alabama at Birmingham 110
Early research (Phase 1)Study completedNCT02044120
What this trial is testing

ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Sarcoma Alliance for Research through Collaboration 34
Testing effectiveness (Phase 2)Study completedNCT00103259
What this trial is testing

Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+22 more
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)UnknownNCT00974389
What this trial is testing

S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery

Who this might be right for
Colorectal Cancer
Osaka Medical College 40
Testing effectiveness (Phase 2)Study completedNCT01467986
What this trial is testing

Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma

Who this might be right for
Neuroblastoma Recurrent
University of Regensburg 130
Large-scale testing (Phase 3)Study completedNCT00265850
What this trial is testing

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 2,334
Early research (Phase 1)Active Not RecruitingNCT02192359
What this trial is testing

Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Recurrent Anaplastic AstrocytomaRecurrent Anaplastic OligoastrocytomaRecurrent Anaplastic Oligodendroglioma+4 more
City of Hope Medical Center 18
Large-scale testing (Phase 3)UnknownNCT04392479
What this trial is testing

TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.

Who this might be right for
Cancer ColorectalMetastasis
Hôpital Franco-Britannique-Fondation Cognacq-Jay 202
Next Page